Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes

NCT02130401 is registered in ClinicalTrials.gov with Scion NeuroStim as lead sponsor.

NCT NCT02130401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02130401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes
Lead sponsor
Scion NeuroStim
Phase
Not applicable
Overall status
Terminated
Start date
June 30, 2014
Completion date
June 30, 2015
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes